Cargando…
Gastric myeloid sarcoma: A case report
BACKGROUND: Myeloid sarcoma (MS) is a rare hematologic malignancy defined as an extramedullary tumor of immature granulocytic cells. It can occur as primary or de novo and be associated with myelodysplasia or myeloproliferative neoplasms. The most frequent locations are the skin, lymph nodes and bon...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546661/ https://www.ncbi.nlm.nih.gov/pubmed/34733617 http://dx.doi.org/10.5306/wjco.v12.i10.960 |
_version_ | 1784590231354212352 |
---|---|
author | Rioja, Patricia Macetas, Jackeline Luna-Abanto, Jorge Tirado-Hurtado, Indira Enriquez, Daniel J |
author_facet | Rioja, Patricia Macetas, Jackeline Luna-Abanto, Jorge Tirado-Hurtado, Indira Enriquez, Daniel J |
author_sort | Rioja, Patricia |
collection | PubMed |
description | BACKGROUND: Myeloid sarcoma (MS) is a rare hematologic malignancy defined as an extramedullary tumor of immature granulocytic cells. It can occur as primary or de novo and be associated with myelodysplasia or myeloproliferative neoplasms. The most frequent locations are the skin, lymph nodes and bones. The case of a patient with a diagnosis of primary granulocytic de novo gastric MS is reported. CASE SUMMARY: A 19-year-old female patient with MS, whose abdominal computed tomography showed a bulky tumor of 16.5 cm in the gastric chamber with infiltration in the retroperitoneal, pancreatic and bile duct region; the histological study showed gastric mucosa diffusely infiltrated by mononucleated cells and the immunohistochemistry expressed myeloperoxidase. After receiving induction chemotherapy based on the 3 + 7 regimen (daunorubicin/cytarabine), the patient developed severe hematological toxicity and neutropenic typhlitis which required a prolonged medical treatment. She presented a rapid disease progression. Although she received supportive treatment, the patient died. CONCLUSION: Gastric primary de novo MS is a rare and aggressive course neoplasm, fostering knowledge is very important to decide its management and to promote more approaches focused on understanding this pathology and its particularities in our population. |
format | Online Article Text |
id | pubmed-8546661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-85466612021-11-02 Gastric myeloid sarcoma: A case report Rioja, Patricia Macetas, Jackeline Luna-Abanto, Jorge Tirado-Hurtado, Indira Enriquez, Daniel J World J Clin Oncol Case Report BACKGROUND: Myeloid sarcoma (MS) is a rare hematologic malignancy defined as an extramedullary tumor of immature granulocytic cells. It can occur as primary or de novo and be associated with myelodysplasia or myeloproliferative neoplasms. The most frequent locations are the skin, lymph nodes and bones. The case of a patient with a diagnosis of primary granulocytic de novo gastric MS is reported. CASE SUMMARY: A 19-year-old female patient with MS, whose abdominal computed tomography showed a bulky tumor of 16.5 cm in the gastric chamber with infiltration in the retroperitoneal, pancreatic and bile duct region; the histological study showed gastric mucosa diffusely infiltrated by mononucleated cells and the immunohistochemistry expressed myeloperoxidase. After receiving induction chemotherapy based on the 3 + 7 regimen (daunorubicin/cytarabine), the patient developed severe hematological toxicity and neutropenic typhlitis which required a prolonged medical treatment. She presented a rapid disease progression. Although she received supportive treatment, the patient died. CONCLUSION: Gastric primary de novo MS is a rare and aggressive course neoplasm, fostering knowledge is very important to decide its management and to promote more approaches focused on understanding this pathology and its particularities in our population. Baishideng Publishing Group Inc 2021-10-24 2021-10-24 /pmc/articles/PMC8546661/ /pubmed/34733617 http://dx.doi.org/10.5306/wjco.v12.i10.960 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Case Report Rioja, Patricia Macetas, Jackeline Luna-Abanto, Jorge Tirado-Hurtado, Indira Enriquez, Daniel J Gastric myeloid sarcoma: A case report |
title | Gastric myeloid sarcoma: A case report |
title_full | Gastric myeloid sarcoma: A case report |
title_fullStr | Gastric myeloid sarcoma: A case report |
title_full_unstemmed | Gastric myeloid sarcoma: A case report |
title_short | Gastric myeloid sarcoma: A case report |
title_sort | gastric myeloid sarcoma: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546661/ https://www.ncbi.nlm.nih.gov/pubmed/34733617 http://dx.doi.org/10.5306/wjco.v12.i10.960 |
work_keys_str_mv | AT riojapatricia gastricmyeloidsarcomaacasereport AT macetasjackeline gastricmyeloidsarcomaacasereport AT lunaabantojorge gastricmyeloidsarcomaacasereport AT tiradohurtadoindira gastricmyeloidsarcomaacasereport AT enriquezdanielj gastricmyeloidsarcomaacasereport |